Dr. Tina S. Rogers, PhD, DABT, MBA is the Vice President, Preclinical Sciences at SNBL U.S.A. Ltd. With over 25 years of experience in the CRO industry, she has held key leadership positions including Executive Vice President and Director of Research at MPI Research Inc. and Vice President of Drug Development at Southern Research Institute.
Dr. Rogers has unique combination of scientific and business experience. Dr. Rogers is currently on the Board of Directors at RenovoNeural, a spinout of the Cleveland Clinic that is focused on neurodegenerative diseases. Previously, she served on the MBA Advisory Board at the Auburn University School of Business and was a member of the Gerson Lehrman Group Healthcare Council. Dr. Rogers received her PhD from the Medical University of South Carolina in Molecular and Cellular Biology and Pathobiology, and completed Postdoctoral Fellowships at Harvard Medical School and Tufts University School of Medicine. Dr. Rogers received an MBA from Auburn University’s Harbert School of Business.